0709 203000 - Nairobi 0709 983000 - Kilifi
0709 203000 - NRB 0709 983000 - Kilifi
0709 203000 - NRB | 0709 983000 - Kilifi

Back Home

Sophie Uyoga/Wellcome Open Res


4 results

Comparative performance of the InBios SCoV-2 Detect (TM) IgG ELISA and the in-house KWTRP ELISA in detecting SARS-CoV-2 spike IgG antibodies in Kenyan populations.Kutima B Kagucia EW Mwai K Kimani M Sigilai A Mugo D Karanja H Gitonga JN Karani A Akech D Toroitich M Karia B Tuju J Ziraba AK Bigogo G Ochieng C Onyango C Lidechi S Munywoki PK Uyoga S Adetifa IMO Oyier LIO Bejon P Scott JAG Agweyu A Warimwe GM Nyagwange J Kenya Sars-CoV-Serology Consortium
Wellcome Open Res, (2024). 9:349

Pharmacokinetics and pharmacodynamics of azithromycin in severe malaria bacterial co-infection in African children (TABS-PKPD): a protocol for a Phase II randomised controlled trial.Olupot-Olupot P Okiror W Mnjalla H Muhindo R Uyoga S Mpoya A Williams TN terHeine R Burger DM Urban B Connon R George EC Gibb DM Walker AS Maitland K
Wellcome Open Res, (2023). 6:161

Revealing the extent of the first wave of the COVID-19 pandemic in Kenya based on serological and PCR-test data.Ojal J Brand SPC Were V Okiro EA Kombe IK Mburu C Aziza R Ogero M Agweyu A Warimwe GM Uyoga S Adetifa IMO Scott JAG Otieno E Ochola-Oyier LI Agoti CN Kasera K Amoth P Mwangangi M Aman R Ng'ang'a W Tsofa B Bejon P Barasa E Keeling MJ Nokes DJ
Wellcome Open Res, (2022). 6:127

Informing thresholds for paediatric transfusion in Africa: the need for a trial.Maitland K Ohuma EO Mpoya A Uyoga S Hassall O Williams TN
Wellcome Open Res, (2019). 4:27